Open Government Portal
Found 10 records similar to HPFB - Summary Reports (SBD/RDS/SSR) API Database
Understand the decisions to approve or not approve the sale of drugs and medical devices in Canada.
MDALL contains product-specific information on all medical devices that are currently licensed for sale in Canada, or have been licensed in the past.
Medical devices imported into Canada for sale, with or without a monetary contribution, must meet Health Canada requirements for commercial importation, as outlined in the Food and Drugs Act (FDA) and the Medical Devices Regulations (MDR).
Summary of the results associated with the data collected on student tobacco, alcohol, and drug use for 2018-19.
Drug and medical device manufacturers submit clinical information to Health Canada for the approval of new products. Health Canada assesses this clinical information to reach a decision on whether or not to approve a drug or medical device.
This notice explains under which circumstances non-medical masks or face coverings would be subject to the regulatory framework for medical devices during the COVID-19 pandemic.
The updated regulations will help drug makers understand what information should be included in their drug submissions. This will help with product approval and availability.
The number and percentage of adjudication decisions and recommendations that are made within legislated time limits and service standards.
This project will build new review pathways for those drugs shown to meet health care system needs. The outcome for the people of Canada will be faster access to drugs, including drugs for rare diseases.